Literature DB >> 15182342

Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia.

Oliver Meyer, Holger Kiesewetter, Manfred Hermsen, Abdulgabar Salama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15182342     DOI： 10.1111/j.1600-0609.2004.00244.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

1.  9 Human Immunoglobulins.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Newly diagnosed immune thrombocytopenia: update on diagnosis and management.

Authors:  Deepak Bansal; Aruna Rajendran; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2013-10-05       Impact factor: 1.967

3.  Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.

Authors:  Ann Reed Gaines; Hallie Lee-Stroka; Karen Byrne; Dorothy E Scott; Lynne Uhl; Ellen Lazarus; David F Stroncek
Journal:  Transfusion       Date:  2009-02-09       Impact factor: 3.157

4.  Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.